Open AccessHigh systemic immune-inflammation index is a predictor of poor prognosis in patients with nonsmall cell lung cancer and bone metastasis
Author(s) -
Shanqi Xu,
Shoubo Cao,
Yan Yu
Publication year - 2021
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_176_21
Subject(s) - medicine , hazard ratio , oncology , univariate analysis , bone metastasis , multivariate analysis , lung cancer , metastasis , subgroup analysis , proportional hazards model , cancer , gastroenterology , confidence interval , chemotherapy , systemic inflammation , inflammation
This study aimed to evaluate whether systemic immune inflammation (SII) is correlated with overall survival (OS) in patients with nonsmall cell lung cancer (NSCLC) and bone metastasis.